Dr. Jimmy Ruiz
Claim this profileWake Forest University Health Sciences
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
24 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Jimmy Ruiz is currently running
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting1 award Phase 119 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Jimmy Ruiz
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jimmy Ruiz has experience with
- Pembrolizumab
- Carboplatin
- Berzosertib
- Gemcitabine Hydrochloride
- Topotecan Hydrochloride
- Zimberelimab
Breakdown of trials Jimmy Ruiz has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jimmy Ruiz specialize in?
Jimmy Ruiz focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jimmy Ruiz currently recruiting for clinical trials?
Yes, Jimmy Ruiz is currently recruiting for 3 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jimmy Ruiz has studied deeply?
Yes, Jimmy Ruiz has studied treatments such as Pembrolizumab, Carboplatin, Berzosertib.
What is the best way to schedule an appointment with Jimmy Ruiz?
Apply for one of the trials that Jimmy Ruiz is conducting.
What is the office address of Jimmy Ruiz?
The office of Jimmy Ruiz is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.